T1	Treatment 0 21	Bismuth subsalicylate
T2	Treatment 145 208	bismuth subsalicylate, erythromycin ethylsuccinate, and placebo
T3	Treatment 224 231	bismuth
T4	Treatment 372 386	active bismuth
T5	Treatment 425 437	erythromycin
T6	Treatment 474 482	placebo.
T7	Treatment 542 549	bismuth
T8	Treatment 584 596	erythromycin
T9	Treatment 630 638	placebo.
T10	Treatment 825 832	bismuth
T11	Treatment 866 874	placebo.
T12	Treatment 890 897	bismuth
T13	Treatment 951 963	Erythromycin
T14	Treatment 1090 1097	bismuth
